Investing.com - Evolent Health Inc (NYSE: EVH) reported fourth quarter EPS of $0.10, in line with the analyst estimate of $0.10. Revenue for the quarter came in at $382.43M versus the consensus estimate of $372.93M.
Guidance
Evolent Health Inc sees Q1 2023 revenue of $420.00M-$440.00M versus the analyst consensus of $410.10M.
Evolent Health Inc sees FY 2023 revenue of $1.92B-$1.96B versus the analyst consensus of $1.88B.
Evolent Health Inc's stock price closed at $31.58. It is up 14.46% in the last 3 months and up 42.19% in the last 12 months.
Evolent Health Inc saw 2 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Evolent Health Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Evolent Health Inc's Financial Health score is "good performance".
Check out Evolent Health Inc's recent earnings performance, and Evolent Health Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar